Enfermedad pulmonar intersticial fibrosante progresiva (EPI-FP)

 

Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data

Maher T et al.
 

Acceder

Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON

Wuyts WA et al.

 

Acceder

Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?

Wijsenbeek MS et al.

 

Acceder

 

Association between monocyte count and ILD progression in subjects with fibrosing ILDs: data from the INBUILD trial

Kreuter M et al.
 

Acceder

Safety and tolerability of nintedanib in patients with fibrosing interstitial lung diseases (ILDs): pooled data from four trials

Valenzuela C et al.
 

Acceder

 

SC-ES-07047